These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Results of using Aredia for hypercalcemia in oncology patients]. Lichinitser MR; Vyshinskaia GV; Kupchan DZ; Liubimova NV Ter Arkh; 1993; 65(9):80-1. PubMed ID: 8303606 [No Abstract] [Full Text] [Related]
25. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates. Heatley S Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026 [TBL] [Abstract][Full Text] [Related]
26. [Bisphosphonates in the treatment concept of metastatic breast carcinoma]. Possinger K; Flath B; Akrivakis K Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):M91-4. PubMed ID: 8964444 [No Abstract] [Full Text] [Related]
27. [Long-term administration of biphosphonates in oncology patients with bone involvement]. Adam Z; Vorlícek J; Tomíska M Vnitr Lek; 1994 Oct; 40(10):671-5. PubMed ID: 7810088 [TBL] [Abstract][Full Text] [Related]
28. [Use of diphosphonates in the treatment of hypercalcemia in multiple myeloma: efficacy of 4-amino-hydroxybutylidene-1,1-bisphosphonate (AHButBP)]. Attardo-Parrinello G; Crema F; Merlini G; Spaghi A; Fiorentini ML Medicina (Firenze); 1988; 8(1):75-6. PubMed ID: 3226251 [No Abstract] [Full Text] [Related]
29. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035 [TBL] [Abstract][Full Text] [Related]
30. [Bisphosphonates in malignant hypercalcemia and bone pain]. Lamy O Rev Med Suisse Romande; 2004 Feb; 124(2):111-4. PubMed ID: 15095627 [TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy. Coleman RE Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153 [TBL] [Abstract][Full Text] [Related]
33. Use of bisphosphonates in skeletal metastasis. Elomaa I Acta Oncol; 2000; 39(4):445-54. PubMed ID: 11041106 [TBL] [Abstract][Full Text] [Related]
34. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review. Bloomfield DJ J Clin Oncol; 1998 Mar; 16(3):1218-25. PubMed ID: 9508210 [TBL] [Abstract][Full Text] [Related]
35. Unproven Efficacy of Low-Dose Bisphosphonates as a Means of Decreasing Bone Metastases and Death in Early Breast Cancer. Powles TJ; Paterson AHG JAMA Oncol; 2018 Nov; 4(11):1477-1478. PubMed ID: 30054612 [No Abstract] [Full Text] [Related]
37. Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma. Lei MM; Tavares E; Buzgo E; Lou U; Raje N; Yee AJ Leuk Lymphoma; 2022 Dec; 63(13):3249-3252. PubMed ID: 36036363 [No Abstract] [Full Text] [Related]
38. [Clinical trial on ibandronate in patients with tumor-associated hypercalcemia]. Wang T; Song ST; Jiang ZF; Bian SG; Wang YJ; Li LQ; Zhu J Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):739-41. PubMed ID: 15733393 [TBL] [Abstract][Full Text] [Related]
39. [Differential diagnosis and therapy of tumor-associated hypercalcemia]. Thomas M; Schneider W Dtsch Med Wochenschr; 1989 Oct; 114(41):1576-81. PubMed ID: 2680409 [No Abstract] [Full Text] [Related]
40. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient. Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]